Skip to main content
. 2013 Jun 14;4:72. doi: 10.3389/fphar.2013.00072

FIGURE 5.

FIGURE 5

Both sub-chronic treatment (A, twice daily, 100 mg/kg, p. o. over 12 days) and acute treatment (B, 100 mg/kg, s.c.) with semagacestat (Smg) significantly reduced brain Aβ levels compared to vehicle-treated controls.